NSE BSE
oxygenta pharmaceutical limite stock

OXYGENTA PHARMACEUTICAL LIMITE Share Price

- - (%)
Sector: -

524636

OXYGENTAPH

img img img img
No Data Available

OXYGENTA PHARMACEUTICAL LIMITE Share Price Update


As of the latest trading session, OXYGENTA PHARMACEUTICAL LIMITE share price is currently at 36.48, which is up by 1.52 from its previous closing. Today, the stock has fluctuated between 35.35 and 36.68. Over the past year, OXYGENTA PHARMACEUTICAL LIMITE has achieved a return of 11.91 %. In the last month alone, the return has been -13.36 %.

OXYGENTA PHARMACEUTICAL LIMITE Performance

Day Range

Low35.35 High36.68
34.98

52 Week Range

Low 25.02 High 52.27
34.98

Open Price

35.35

Prev. Close

34.95

Volume (Shares)

7513.00

Total traded value

2.62

Upper Circuit

34.21

Lower Circuit

30.97

Note: The current prices & values are delayed, Login to your account for live updates.

OXYGENTA PHARMACEUTICAL LIMITE Fundamentals


(Standalone)

Market Cap (Cr) 122.10
PE Ratio (TTM) 0.00
Book Value / Share -7.46
Beta 0.71
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -3.78

OXYGENTA PHARMACEUTICAL LIMITE Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 9.15
Operating Expense 12.67
Net Profit -3.78
Net Profit Margin (%) -41.31
Earnings Per Share (EPS) -0.99
EBITDA -2.50
Effective Tax Rate (%) -6.47
Particulars SEP 2023 (Values in Cr)
Revenue 13.08
Operating Expense 16.23
Net Profit -3.16
Net Profit Margin (%) -24.15
Earnings Per Share (EPS) -0.87
EBITDA -2.01
Effective Tax Rate (%) 0.62
Particulars JUN 2023 (Values in Cr)
Revenue 6.86
Operating Expense 11.29
Net Profit -4.56
Net Profit Margin (%) -66.47
Earnings Per Share (EPS) -1.65
EBITDA -3.76
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 8.19
Operating Expense 12.21
Net Profit -4.29
Net Profit Margin (%) -52.38
Earnings Per Share (EPS) -3.02
EBITDA -2.30
Effective Tax Rate (%) -4.88
Particulars DEC 2022 (Values in Cr)
Revenue 7.85
Operating Expense 10.78
Net Profit -3.25
Net Profit Margin (%) -41.40
Earnings Per Share (EPS) -2.29
EBITDA -2.65
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 30.99
Operating Expense 41.65
Net Profit -11.57
Net Profit Margin (%) -37.33
Earnings Per Share (EPS) -6.36
EBITDA -7.82
Effective Tax Rate (%) -1.75
Particulars MAR 2022 (Values in Cr)
Revenue 60.52
Operating Expense 61.56
Net Profit -0.61
Net Profit Margin (%) -1.00
Earnings Per Share (EPS) -0.48
EBITDA 2.02
Effective Tax Rate (%) -24.48
Particulars MAR 2021 (Values in Cr)
Revenue 52.03
Operating Expense 51.18
Net Profit 2.93
Net Profit Margin (%) 5.63
Earnings Per Share (EPS) 2.87
EBITDA 6.11
Effective Tax Rate (%) 6.38
Particulars MAR 2020 (Values in Cr)
Revenue 13.72
Operating Expense 23.66
Net Profit -5.79
Net Profit Margin (%) -42.20
Earnings Per Share (EPS) -5.67
EBITDA -3.85
Effective Tax Rate (%) 2.52
Particulars MAR 2019 (Values in Cr)
Revenue 20.51
Operating Expense 24.32
Net Profit -3.25
Net Profit Margin (%) -15.84
Earnings Per Share (EPS) -3.19
EBITDA -1.72
Effective Tax Rate (%) 6.87
Particulars MAR 2023 (Values in Cr)
Book Value / Share -32.53
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -25.27
Particulars MAR 2022 (Values in Cr)
Book Value / Share -24.38
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 2.43
Particulars MAR 2021 (Values in Cr)
Book Value / Share -37.27
ROE % -5.79
ROCE % 7.89
Total Debt to Total Equity 0.00
EBITDA Margin 7.55
Particulars MAR 2020 (Values in Cr)
Book Value / Share -40.14
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -57.14
Particulars MAR 2019 (Values in Cr)
Book Value / Share -34.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -8.39
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 54.26
Total Liabilities 54.26
Total Equity -46.20
Share Outstanding 14201300
Price to Book Ratio -1.13
Return on Assets (%) -21.32
Return on Capital (%) -53.09
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 31.17
Total Liabilities 31.17
Total Equity -34.62
Share Outstanding 14201300
Price to Book Ratio -0.99
Return on Assets (%) -1.95
Return on Capital (%) -3.49
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 33.86
Total Liabilities 33.86
Total Equity -38.01
Share Outstanding 10201300
Price to Book Ratio 0.00
Return on Assets (%) 8.65
Return on Capital (%) 29.69
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 18.62
Total Liabilities 18.62
Total Equity -40.94
Share Outstanding 10201300
Price to Book Ratio 0.00
Return on Assets (%) -31.08
Return on Capital (%) 38.56
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 21.15
Total Liabilities 21.15
Total Equity -35.16
Share Outstanding 10201300
Price to Book Ratio 0.00
Return on Assets (%) -15.37
Return on Capital (%) 23.58
Particulars MAR 2023 (Values in Cr)
Net Income -11.37
Cash from Operations -1.43
Cash from Investing -9.63
Cash from Financing 11.22
Net change in Cash -0.04
Free Cash Flow 8.20
Particulars MAR 2022 (Values in Cr)
Net Income -0.48
Cash from Operations -1.55
Cash from Investing -4.94
Cash from Financing 6.33
Net change in Cash -0.28
Free Cash Flow 3.38
Particulars MAR 2021 (Values in Cr)
Net Income 3.14
Cash from Operations -1.40
Cash from Investing -6.71
Cash from Financing 8.66
Net change in Cash 0.32
Free Cash Flow 5.33
Particulars MAR 2020 (Values in Cr)
Net Income -5.94
Cash from Operations -2.74
Cash from Investing -0.49
Cash from Financing 3.18
Net change in Cash 0.09
Free Cash Flow -2.22
Particulars MAR 2019 (Values in Cr)
Net Income -3.49
Cash from Operations -8.03
Cash from Investing -0.55
Cash from Financing 8.35
Net change in Cash 0.00
Free Cash Flow -7.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8857.55 35.96 20.09 20398.94 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
OXYGENTA PHARMACEUTICAL LIMITE 34.95 0.00 -4.68 117.02 25.02 / 52.27
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 34.30
  • 26 Days 36.40
  • 10 Days 35.20
  • 50 Days 35.60
  • 12 Days 35.50
  • 100 Days 34.50
  • 20 Days 36.60
  • 200 Days 39.30
34.51
PIVOT
First Resistance 36.20
Second Resistance 37.46
Third Resistance 39.15
First Support 33.25
Second Support 31.56
Third Support 30.30
RSI 31.98
MACD -0.90
Commodity Channel Index (CCI) -99.69
ADX 15.59
Williams % R -68.07

Over 1 Month

down

-13.36

Over 3 Months

down

9.83

Over 6 Months

down

10.95

Over 1 Year

down

11.91

Over 3 Years

down

53.99

Over 5 Years

down

34.98

OXYGENTA PHARMACEUTICAL LIMITE Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

OXYGENTA PHARMACEUTICAL LIMITE Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
70.24
Promoter Holdings
29.72
FII
0.0
DII
0.02
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sravani Reddy Gantla Public Shareholding 4487000.0 13.4
Sunil Vishram Chawda Shareholding of Promoter and Promoter Group 4161200.0 12.43
Qemiq Pharma Private Limited Public Shareholding 3952600.0 11.8
Pushpalatha Vustala Public Shareholding 3000000.0 8.96
Sandeep Kumar Reddy Kommidi Public Shareholding 2756500.0 8.23
Aakanksha M Chawda Shareholding of Promoter and Promoter Group 1582500.0 4.73
Manoj Sunil Chawda Shareholding of Promoter and Promoter Group 1582500.0 4.73
Subba Reddy Bhimavarapu Public Shareholding 1532800.0 4.58
Snigdha Vankineni Shareholding of Promoter and Promoter Group 1143000.0 3.41
K. Raghavender Rao Shareholding of Promoter and Promoter Group 800000.0 2.39
Hemanth Kumar Kowdi Public Shareholding 500000.0 1.49
Sanagari Kondal Reddy Public Shareholding 500000.0 1.49
Kishore Babu Bathula Public Shareholding 500000.0 1.49
B Subba Reddy Public Shareholding 467400.0 1.4
Srivani Junoothula Public Shareholding 380000.0 1.13
Sumanth Simha Vankineni Shareholding of Promoter and Promoter Group 343700.0 1.03
Sai Sudhakar Vankineni Shareholding of Promoter and Promoter Group 230000.0 0.69
Sadasiva Reddy Devagudi Shareholding of Promoter and Promoter Group 84400.0 0.25
Jhansi Rani Vankineni Shareholding of Promoter and Promoter Group 26000.0 0.08

OXYGENTA PHARMACEUTICAL LIMITE

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About OXYGENTA PHARMACEUTICAL LIMITE

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by OXYGENTA PHARMACEUTICAL LIMITE

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Oxygenta Pharmaceutical Ltd?

Answer Field

The share price of Oxygenta Pharmaceutical Ltd for NSE is ₹ 0.00 and for BSE is ₹ 36.48.

What is the Market Cap of Oxygenta Pharmaceutical Ltd?

Answer Field

The market cap of Oxygenta Pharmaceutical Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 122.10 Cr. as of now.

What is the 52 Week High and Low of Oxygenta Pharmaceutical Ltd?

Answer Field

The 52 Week High and Low of Oxygenta Pharmaceutical Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 52.27 and ₹ 25.02.

How to Buy Oxygenta Pharmaceutical Ltd share?

Answer Field

You can trade in Oxygenta Pharmaceutical Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Oxygenta Pharmaceutical Ltd?

Answer Field

The 1 year returns on the stock has been 11.91%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader